^
Contact us to learn more about
our Premium Content: News alerts, weekly reports and conference plannersDRUG:
CHZ868
i
Other names: CHZ868, NVP-CHZ868, CHZ 868, NVP CHZ868, CHZ-868, NVPCHZ868
Contact us to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Company:
Memorial Sloan-Kettering Cancer Center, Novartis
Drug class:
JAK2 inhibitor
Related drugs:
